FDA Variance Approval Letter to DePaul University
Summary
The FDA's Center for Devices and Radiological Health (CDRH) has issued a variance approval letter to DePaul University's Idea Realization Laboratory. This document signifies approval for a specific variance related to medical device development or testing.
What changed
The FDA's Center for Devices and Radiological Health (CDRH) has issued a variance approval letter to DePaul University's Idea Realization Laboratory. This document, identified by docket number FDA-2026-V-1761-0004, indicates that the university has received approval for a specific variance, likely related to the development, testing, or regulation of medical devices under FDA oversight.
While this is an approval for a specific entity, other educational institutions or research laboratories involved in medical device innovation may find this document informative regarding the FDA's variance approval process. Compliance officers should note that specific details regarding the nature of the variance and its implications are not publicly available in the provided summary, and further review of the attached document would be necessary for a comprehensive understanding of any potential impact on broader compliance strategies.
Source document (simplified)
Content
There are no documents available to view or download
Attachments 1
Variance Approval Letter from FDA CDRH to DePaul University, Idea Realization Laboratory
More Information
- Author(s) CDRH
Download
Related changes
Source
Classification
Who this affects
Taxonomy
Browse Categories
Get Healthcare alerts
Weekly digest. AI-summarized, no noise.
Free. Unsubscribe anytime.
Get alerts for this source
We'll email you when Regs.gov: Food and Drug Administration publishes new changes.